Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - SKINOVATION PHARMACEUTICAL INC | skin0806form10q.htm |
| EX-31 - EXHIBIT 31.1 - SKINOVATION PHARMACEUTICAL INC | skin0806form10qex311.htm |
| EX-31 - EXHIBIT 31.2 - SKINOVATION PHARMACEUTICAL INC | skin0806form10qex312.htm |
| EXCEL - IDEA: XBRL DOCUMENT - SKINOVATION PHARMACEUTICAL INC | Financial_Report.xls |
Exhibit 32.1
SKINOVATION PHARMACEUTICAL INCORPORATED
CERTIFICATION OF PERIODIC REPORT
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
18 U.S.C. Section 1350
The undersigned executive officer of Skinovation Pharmaceutical Incorporated certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:
| a. | the quarterly report on Form 10-Q of Skinovation Pharmaceutical Incorporated for the quarter ended June 30, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| b. | the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Skinovation Pharmaceutical Incorporated. |
|
Date: August 8, 2013 |
/s/ Hugo Rodier Hugo Rodier Principal Executive Officer Principal Financial Officer |